Aducanumab Biosimilar - Research Grade,ichor.bio,ICH5008

Detects human Beta Amyloid. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Aducanumab.

Host

CHO cells

Reactivity

Human

Platform ID

BAB320334195

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

Contact

Tel:
Fax:

Product Specifications
Scientific Background
Synonyms

Specifications

NameAducanumab Biosimilar - Research Grade
Cat. No.ICH5008
Accession NumberP05067
HostCHO cells
IsotypeHuman IgG1
ReactivityHuman
Concentration5mg/ml
TargetBeta Amyloid
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only

Scientific Background

RUO Aducanumab is a human monoclonal antibody that selectively targets aggregated amyloid beta. In a transgenic mouse model of Alzheimerï؟½s disease, aducanumab is shown to enter the brain, bind parenchymal amyloid beta, and reduce soluble and insoluble a

Synonyms

Aducanumab-avwa, BIIB037, BIIB-037

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.